This horse deader than dead when ILMN's lawyer team destroyed the community college kid who worked for free this week...
-
-
@ singlemoleculer
Thanks for your advices. I checked my sequences but I am not sure about some points:
What does very rich of A's and T's mean? Do you have a percentage? The same with the low number of G's.
Of course I find CTAG's but where is the limit?
I also find many sequences with long stretches of polyA's polyT's? Is this also an indicator for bad sequencing?Comment
-
The standard Helicos filtering software gets rid of these artifacts automatically. If you don't have access to the software, you can do manual filtering. Very rich in AT means A+T>90%. These are usually caused by problems in sample preparation. Any such sequences should be discarded unless you are working with a very AT-rich set of sequences like Plasmodium in which case you have to adjust the cutoff. For CTAG, you should look at the dimer frequencies. If CT+TA+AG+GC>70%, you should also discard. These sequences are usually caused when 2 DNAs are too close on the flow cell and the signals overlap. The filtering software actually has a more complex algorithm but this is good enough for most purposes.Comment
-
Thanks for your reply.
I did use the Helipshere software for the analyis so the artifacts should be removed automatically. But I will check the nucleotide distribution of my unaligned sequences allos manually.Comment
-
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM -
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM
Comment